```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10497 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                               H. R. 10497

To amend title 18, United States Code, to provide for certain rules for 
    housing or transportation based on gender and to provide for a 
            limitation on gender-related medical treatment.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 18, 2024

   Ms. Mace introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend title 18, United States Code, to provide for certain rules for 
    housing or transportation based on gender and to provide for a 
            limitation on gender-related medical treatment.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prison Rape Prevention Act of 
2024''.

SEC. 2. RULES FOR HOUSING OR TRANSPORTATION BASED ON GENDER; LIMITATION 
              ON GENDER-AFFIRMING CARE.

    Section 3621 of title 18, United States Code, is amended by adding 
at the end the following:
    ``(j) Rules for Housing or Transportation Based on Gender; 
Limitation on Gender-Affirming Care.--Notwithstanding any other 
provision of law, the Bureau of Prisons--
            ``(1) shall ensure that a prisoner is placed, during that 
        prisoner's term of imprisonment, only among prisoners of the 
        same biological sex as the prisoner;
            ``(2) shall ensure that a prisoner, when transported in the 
        company of other prisoners, is only transported among prisoners 
        of the same biological sex as the prisoner; and
            ``(3) may not furnish or pay for any gender-related medical 
        treatment.
    ``(k) Definitions.--For purposes of subsection (j):
            ``(1) Biological sex.--The term `biological sex' means the 
        biological determination as to whether an individual is male or 
        female.
            ``(2) Female.--The term `female' means an individual who 
        naturally has, had, will have, or would have, but for a 
        developmental or genetic anomaly or historical accident, the 
        reproductive system that at some point produces, transports, 
        and utilizes eggs for fertilization.
            ``(3) Male.--The term `male' means an individual who 
        naturally has, had, will have, or would have, but for a 
        developmental or genetic anomaly or historical accident, the 
        reproductive system that at some point produces, transports, 
        and utilizes sperm for fertilization.
            ``(4) Gender.--The term `gender'--
                    ``(A) means--
                            ``(i) males, females, or the natural 
                        differences between males and females, unless 
                        such term is otherwise specified or used alone 
                        (rather than with or as an adjective modifying 
                        other words); and
                            ``(ii) a synonym for sex; and
                    ``(B) does not mean a synonym for terms or ideas 
                such as gender identity, experienced gender, gender 
                expression, or gender roles
            ``(5) Gender-related medical treatment.--The term `gender-
        related medical treatment'--
                    ``(A) means--
                            ``(i) with respect to a female individual, 
                        medical treatments provided for purposes of 
                        addressing the perception of such individual 
                        that the gender or sex of such individual is 
                        not female, including--
                                    ``(I) surgical procedures, 
                                including--
                                            ``(aa) vaginectomy;
                                            ``(bb) hysterectomy;
                                            ``(cc) oophorectomy;
                                            ``(dd) reconstruction of 
                                        the urethra;
                                            ``(ee) metoidioplasty;
                                            ``(ff) phalloplasty;
                                            ``(gg) salpingo-
                                        oophorectomy;
                                            ``(hh) scrotoplasty;
                                            ``(ii) implantation of 
                                        erection or testicular 
                                        protheses;
                                            ``(jj) subcutaneous 
                                        mastectomy;
                                            ``(kk) vocal cord surgery;
                                            ``(ll) pectoral implants; 
                                        and
                                            ``(mm) penile 
                                        transplantation;
                                    ``(II) exogenous doses of 
                                testosterone or other androgens;
                                    ``(III) puberty blockers, 
                                including--
                                            ``(aa) GnRH agonists; and
                                            ``(bb) synthetic drugs that 
                                        suppress the production of 
                                        estrogen and progesterone or 
                                        delay or suppress pubertal 
                                        development in female 
                                        individuals; and
                                    ``(IV) such other medical 
                                treatment, identified by the Director 
                                of the Federal Bureau of Prisons, that 
                                may be provided for purposes of 
                                addressing the perception of such 
                                individual that the gender or sex of 
                                such individual is not female; and
                            ``(ii) with respect to a male individual, 
                        medical treatments provided for purposes of 
                        addressing the perception of such individual 
                        that the gender or sex of such individual is 
                        not male, including--
                                    ``(I) surgical procedures, 
                                including--
                                            ``(aa) penectomy;
                                            ``(bb) orchiectomy;
                                            ``(cc) vaginoplasty;
                                            ``(dd) clitoroplasty;
                                            ``(ee) vulvoplasty;
                                            ``(ff) augmentation 
                                        mammoplasty;
                                            ``(gg) facial feminization 
                                        surgery;
                                            ``(hh) vocal cord surgery;
                                            ``(ii) 
                                        chondrolaryngoplasty;
                                            ``(jj) gluteal 
                                        augmentation; and
                                            ``(kk) uterine 
                                        transplantation;
                                    ``(II) exogenous doses of estrogen;
                                    ``(III) puberty blockers, 
                                including--
                                            ``(aa) GnRH agonists; and
                                            ``(bb) synthetic drugs that 
                                        suppress the production of 
                                        testosterone or delay or 
                                        suppress pubertal development 
                                        in male individuals; and
                                    ``(IV) such other medical 
                                treatment, identified by the Director 
                                of the Federal Bureau of Prisons, that 
                                may be provided for purposes of 
                                addressing the perception of such 
                                individual that the gender or sex of 
                                such individual is not male; and
                    ``(B) does not include any medical treament 
                performed on an individual for the purposes of 
                treating--
                            ``(i) a disorder of sex development, 
                        diagnosed by a physician after such physician 
                        has determined through genetic or biochemical 
                        testing that such individual does not have 
                        normal sex chromosome structure, sex steroid 
                        hormone production, or sex steroid hormone 
                        action;
                            ``(ii) irresolvably ambiguous biological 
                        sex characteristics of such individual, 
                        including the presence of--
                                    ``(I) 46 XX chromosomes with 
                                virilization;
                                    ``(II) 46 XY chromosomes with 
                                undervirilization; or
                                    ``(III) both ovarian and testicular 
                                tissue; or
                            ``(iii) an infection, injury, disease, or 
                        disorder caused or exacerbated by gender-
                        related medical treatment that was furnished to 
                        an individual.''.
                                 <all>
```